Free Trial

DBV Technologies (DBVT) Insider Trading & Ownership

DBV Technologies logo
$3.21 -0.01 (-0.31%)
(As of 12/17/2024 05:56 PM ET)

DBV Technologies (NASDAQ:DBVT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.90%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$1,619.80
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$4,762.35
Get DBVT Insider Trade Alerts

Want to know when executives and insiders are buying or selling DBV Technologies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

DBVT Insider Buying and Selling by Quarter

DBV Technologies Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/25/2024Pharis MohideenInsiderSell113$2.85$322.05  
11/21/2024Pharis MohideenInsiderSell470$2.70$1,269.00  
7/29/2024Pharis MohideenInsiderSell357$4.90$1,749.30  
5/24/2024Pharis MohideenInsiderSell66$13.60$897.60  
5/22/2024Pharis MohideenInsiderSell38$13.80$524.40  
2/6/2024Adora NduDirectorBuy182$8.90$1,619.80  
(Data available from 1/1/2013 forward)

DBVT Insider Trading Activity - Frequently Asked Questions

The list of insiders at DBV Technologies includes Adora Ndu, Daniel B Soland, Pharis Mohideen, and Timothy E Morris. Learn more on insiders at DBVT.

1.90% of DBV Technologies stock is owned by insiders. Learn more on DBVT's insider holdings.

The following insiders have purchased DBVT shares in the last 24 months: Adora Ndu ($1,619.80), Daniel B Soland ($24,300.00), and Timothy E Morris ($18,240.00).

Insiders have purchased a total of 2,882 DBVT shares in the last 24 months for a total of $44,159.80 bought.

The following insider sold DBVT shares in the last 24 months: Pharis Mohideen ($6,390.75).

Insiders have sold a total of 1,090 DBV Technologies shares in the last 24 months for a total of $6,390.75 sold.

DBV Technologies Key Executives

  • Mr. Daniel Tassé (Age 64)
    CEO & Director
    Compensation: $1.32M
  • Ms. Virginie Simone Jeanine Verrechia Boucinha M.B.A. (Age 55)
    CFO & Principal Accounting Officer
    Compensation: $324.23k
  • Dr. Pharis Mohideen (Age 59)
    Chief Medical Officer
    Compensation: $929.4k
    3 recent trades
  • Dr. Kevin P. Malobisky M.S.
    Ph.D., R.A.C., Chief Operations Officer
  • Katie Matthews
    Investor Relations Officer
  • Ms. Michele F. Robertson
    Chief Legal Officer
  • Ms. Caroline Daniere (Age 49)
    Chief Human Resources Officer & Chief of Staff
  • Dr. Wence Agbotounou
    Chief Clinical Trial Officer & Senior VP
  • Mr. Edward P. Jordan M.B.A. (Age 56)
    Senior Vice President of Commercial Operations North America
  • Alan Kerr
    Senior VP & Head of Global Regulatory Affairs


This page (NASDAQ:DBVT) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners